G-3′). All oligos were purchased from Integrated DNA Technologies with standard desalting. DNA fragments between 175 and 450 bp in size from the amplicon libraries were excised from the agarose gel and quantified using a Qubit Fluorometer, Agilent 2100 Bioanalyzer and qRT-PCR. Excised libraries were then pooled, loaded onto two flow cell lanes and sequenced on the Hiseq2500 platform. Sequencing reads were converted to FASTQ format and demultiplexed using bcl2fastq-1.8.4 (Illumina) at Eurofins Genomics. Reads with a dual index that did not match the barcode were discarded, and reads with a matching dual index had the index and preceding sequence removed. Next, the p1 primer sequence was clipped from reads, and reads were mapped to the mouse genome using the SBCapSeq pipeline (4).
Common insertion site analysis
Due to the local hopping phenomena (62), all insertions on chromosome 4 in tumors from 6070 and chromosome 1 in tumors from 6113 were removed, as these insertions resided on the chromosome containing the T2/Onc2 donor concatamer. Insertions in Sfi1 were removed due to Sfi1 being annotated in multiple different genomic loci, as were insertions in En2 and Foxf2, which are known SB hotpots (63). CCGs were identified by applying gCIS (30), to insertions with >50 sequence read counts. Genes with a Bonferroni adjusted P value <0.05 were defined as CCGs. We also obtained bed files from the previous SB screens (6, 7) and performed gCIS analysis using insertions with read counts >3. It should be noted that the sequencing method used for insertion site recovery in the earlier studies (6, 7) was less sensitive than the newer method used in this study.
For trunk driver analysis, we took the bed files and normalized reads on a per-tumor basis by dividing the depth at each insertion by the total number of reads in that tumor. This resulted in percentage of total insertions for each insertion site in each tumor. We then ran gCIS analysis, using insertions which have >2% of total insertions. Genes with a Bonferroni adjusted P value < 0.05 were defined as candidate trunk drivers.
Since we used multiple tumors from the same animal for sequencing in a few mice, we determined the possibility that tumors from the same mice were not independent of each other. The CCGs from the gCIS analysis results (using a cutoff of 200 reads) in each tumor were cataloged and tallied. This generated a matrix, initialized to zero, whose rows were CCGs and tumors were columns. If a CCG was in a tumor, the value at the corresponding row and column was given a value of 1. Then, the Spearman correlation coefficient for each tumor pair was calculated in the dataset. The resulting correlation values were placed into two groups: one group for tumor pairs from the same mice (within group), and one group for tumor pairs from different mice (between group). We then made a normalized histogram for each group from the Pten KO cohort (SI Appendix, Figure S10A ) and the HFD cohort (SI Appendix, Figure S10B ). The resulting distributions were similar, indicating that overall tumors from the same mice were as independent as tumors from different mice.
WST-1 Cell Proliferation Assays
WST-1 assays were performed using the Premix WST-1 cell proliferation assay system (Clontech, Mountain View, CA) according to the manufacturer's protocol.
Briefly, 4x10
3 LPCs were seeded into 96-well plates and cultured with medium containing 10% fetal bovine serum for 1-5 days. WST-1 regent was then added to each well and incubated for 1.5 hours at 37C. The absorbance at 450 nm and 650 nm (reference) was then measured using an Infinite 200 pro-multimode reader (TECAN, San Jose, CA).
Histological analysis
Mouse tissue specimens were fixed in 10% neutral buffered formalin, dehydrated, and embedded in paraffin. Five micron tissue sections were deparaffinized, rehydrated, and stained with H&E for histopathologic evaluation.
For detection of apoptotic cells, the liver sections were also subjected to TUNEL staining as previously described (8). To assess fibrosis, the liver sections were stained with Picrosirius red and counterstained with hematoxylin. To assess lipid accumulation in the liver, the frozen sections of liver were stained with Oil Red O according to the manufacturer's protocol. For immunostaining, paraffin sections with antigen retrieval were incubated overnight with antibody for Yap1 (1:100 dilution, Abcam) and F4/80 (1:100 dilution, Bio-Rad). After secondary antibody incubation, chromogen detection and hematoxylin counterstaining were performed.
Tumorsphere assays 4x10 3 LPCs were seeded on 6-well, ultra-low attachment culture plates, with defined medium (DMEM/F-12 with 20ng/mL EGF (GIBCO), N-2 supplement (Thermo Fisher Scientific) and B27 supplement minus Vitamin A 50X (Thermo Fisher Scientific)). Cells were cultured for 7 days and microscopically monitored for tumorsphere formation.
Lentiviral Transduction
Packaging of lentivirus containing GIPZ Pten shRNA or non-targeting shRNA (negative control) (GE Dharmacon), or doxycycline-inducible Yap expression vector, were performed following the standard protocol (9). Briefly, HEK293T cells were transfected with the mixture of the lentiviral vector, pVSVg (Addgene) and psPAX2 (Addgene) using Lipofectamine 2000. After 6h, the media was changed to DMEM with 1% FBS. After 48-72h, the supernatant containing viral particles were collected and filtered. For lentivirus transduction, LPCs were plated at a density of 1x10 5 cells per 6-well plate, 1 day before the infection. The next day, the medium was changed into serum-free medium containing 8 ug/mL of polybrene (Millipore) and transduced with lentivirus at a multiplicity of infection of 1.0. The following day, cells were supplemented with complete medium containing 1.5mg/mL puromycin for shRNA plasmid and 200μg/mL G418 for 
Quantitative Reverse-Transcription PCR
Total RNA was extracted from cells using the RNeasy Plus Mini kit (Qiagen).
Reverse transcription was performed using SuperScript VILO Master Mix (Thermo Fisher Scientific). Quantitative PCR was performed using the Quant-Studio 12K Flex Reverse-Transcription PCR system with TaqMan Gene Expression Assay probes (Thermo Fisher Scientific). A list of TaqMan probes is provided in SI Appendix, Table S5 .
Western Blot
Cells were lysed in RIPA buffer (Pierce) with protease and phosphatase inhibitor cocktail (Pierce) on ice. The cell lysates were cleared by centrifugation at 10,000g for 15 minutes at 4C. The protein concentrations were determined using a bicinchoninic acid protein assay kit (Pierce). The protein lysates were separated electrophoretically with sodium dodecyl sulfate polyacrylamide gels and transferred onto a polyvinylidene fluoride membrane. For immunodetection, the following antibodies were used: anti-Pten, anti-Yap, anti-phospho-Yap, anti-b-actin (Cell Signaling Technology), anti-Flag (Sigma-Aldrich). Detection of immunolabeled proteins was performed using a chemiluminescent substrate (Thermo Fisher Scientific).
Bioinformatic Analysis
Mouse CCGs were converted to human genes using BioMart-Ensembl tallied. This generated a matrix, initialized to zero, whose rows were CCGs and tumors were columns. If a CCG was in a tumor, the value at the corresponding row and column was given a value of 1. Then, the Spearman correlation coefficient for each tumor pair was calculated in the dataset. The resulting correlation values were placed into two groups: one group for tumor pairs from the same mice (within group), and one group for tumor pairs from different mice (between group). We then made a normalized histogram for each group from Pten KO cohort (A) and HFD cohort (B). The resulting distributions are similar, indicating that overall tumors from the same mice are as independent as tumors from different mice. 
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